Abstract
The discovery that missense mutations in the alpha-synuclein gene represent a rare genetic cause of Parkinson's disease (PD) has had significant impact on the development of research into neurodegenerative disorders. It is becoming increasingly clear that alpha-synuclein plays a central role in the pathological process, which causes Lewy body formation and neurodegeneration in PD. Importantly, there is evidence to suggest that mutated alpha-synuclein is toxic to both nerve cells and glia. However, the regulation and function of wild-type alpha-synuclein are as yet ill defined. Using the facial nerve axotomy model, we have addressed the question whether the expression of alpha-synuclein in nerve cells may change in response to injury. We were particularly interested in testing the hypothesis that the severity of neuronal injury had an effect on alpha-synuclein metabolism. Facial nerve cut and crush, respectively, were performed in adult rats where normal facial motoneurones do not express alpha-synuclein. Following axotomy, a subset of facial motoneurones newly expressed high levels of alpha-synuclein immunoreactivity in their cell body and, occasionally, their nucleus. Significantly more nerve cells were labelled following facial nerve transection than following facial nerve crush. Confocal microscopy revealed a granular pattern of alpha-synuclein aggregation in degenerating nerve cells. Interestingly, the observed cell death phenotype was clearly non-apoptotic and developed over days or weeks rather than hours. Thus, axotomy of adult rat facial motoneurones triggers de novo expression of alpha-synuclein and this expression is associated with a non-apoptotic, slow form a neurodegeneration. In addition, the extent of alpha-synuclein expression is related to the severity of neuronal injury.
Similar content being viewed by others
References
Abeliovich, A., Schmitz, Y., Farinas, I., Choilundberg, D., Ho, W. H., Castillo, P. E., Shinsky, N., Verdugo, J. M., Armanini, M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D. & Rosenthal, A. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239–252.
Baba, M., Nakajo, S., Tu, P. H., Tomita, T., Nakaya, K., Lee, V. M., Trojanowski, J. Q. & Iwatsubo, T. (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. American Journal of Pathology 152, 879–884.
Blinzinger, K. & Kreutzberg, G. W. (1968) Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Zeitschrift für Zellforschung 85, 145–157.
Conway, K. A., Harper, J. D. & Lansbury, P. T. (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nature Medicine 4, 1318–1320.
Conway, K. A., Harper, J. D. & Lansbury, P. T., Jr. (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39, 2552–2563.
Dai, C. F., Kanoh, N., Li, K. Y. & Wang Z. (2000) Study on facial motoneuronal death after proximal or distal facial nerve transection. American Journal of Otology 21, 115–118.
Dal Canto, M. C. & Gurney, M. E. (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. American Journal of Pathology 145, 1271–1279.
Davies, S. W., Turmaine, M., Cozens, B. A., Raza, A. S., Mahal, A., Mangiarini, L. & Bates, G. P. (1999) From neuronal inclusions to neurodegeneration: Neuropathological investigation of a transgenic mouse model of Huntington's disease. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 354, 981–989.
El-Agnaf, O. M., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D. & Wallace, A. (1998) Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. Federation of European Biochemical Societies Letters 440, 71–75.
Fawcett, J. W. & Keynes, R. J. (1990) Peripheral nerve regeneration. Annual Review of Neuroscience 13, 43–60.
George, J. M., Jin, H., Woods, W. S. & Clayton, D. F. (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15, 361–372.
Giasson, B. I., Uryu, K., Trojanowski, J. Q. & Lee, V. M. (1999) Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. Journal of Biological Chemistry 274, 7619–7622.
Goedert, M. (1999) Filamentous nerve cell inclusions in neurodegenerative diseases: Tauopathies and alpha-synucleinopathies. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 354, 1101–1118.
Graeber, M. B., Grasbon-Frodl, E., Abell-Aleff, P. & KÓsel, S. (1999) Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson's disease. Parkinsonism & Related Disorders 5, 187–192.
Graeber, M. B. & Kreutzberg, G. W. (1986) Astrocytes increase in glial fibrillary acidic protein during retrograde changes of facial motor neurons. Journal of Neurocytology 15, 363–373.
Hashimoto, M., Hsu, L. J., Sisk, A., Xia, Y., Takeda, A., Sundsmo, M. & Masliah, E. (1998) Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease. Brain Research 799, 301–306.
Hsu, L. J., Mallory, M., Xia, Y., Veinbergs, I., Hashimoto, M., Yoshimoto, M., Thal, L. J., Saitoh, T. & Masliah, E. (1998) Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. Journal of Neurochemistry 71, 338–344.
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H. A., Kittel, A. & Saitoh, T. (1995) The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467–475.
Jensen, P. H. & Gai, W. P. (2001) Alpha-synuclein. Axonal transport, ligand interaction and neurodegeneration. Advances in Experimental Medicine and Biology 487, 129–134.
Jensen, P. H., Li, J. Y., Dahlstrom, A. & Dotti, C. G. (1999) Axonal transport of synucleins is mediated by all rate components. European Journal of Neuroscience 11, 3369–3376.
Jensen, P. H., Nielsen, M. S., Jakes, R., Dotti, C. G. & Goedert, M. (1998) Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. Journal of Biological Chemistry 273, 26292–26294.
Kashihara, Y., Kuno, M. & Miyata, Y. (1987) Cell death of axotomized motoneurones in neonatal rats, and its prevention by peripheral reinnervation. Journal of Physiology 386, 135–148.
Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., KÓsel, S., Przuntek, H., Epplen, J. T., Schols, L. & Riess, O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature Genetics 18, 106–108.
Li, L. X., Houenou, L. J., Wu, W. T., Lei, M., Prevette, D. M. & Oppenheim, R. W. (1998) Characterization of spinal motoneuron degeneration following different types of peripheral nerve injury in neonatal and adult mice. Journal of Comparative Neurology 396, 158–168.
Lieberman, A. R. (1971) The axon reaction: A review of the principal features of perikaryal responses to axon injury. International Review of Neurobiology 14, 49–124.
Majno, G. & Joris, I. (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. American Journal of Pathology 146, 3–15.
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. & Mucke, L. (2000) Dopaminergic loss and inclusion body formation in alphasynuclein mice: Implications for neurodegenerative disorders. Science 287, 1265–1269.
Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F., Sitney, K., Denis, P., Louis, J. C., Wypych, J., Biere, A. L. & Citron, M. (1999) Both familial Parkinson's disease mutations accelerate alphasynuclein aggregation. Journal of Biological Chemistry 274, 9843–9846.
Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J. & Wolozin, B. (1999) Alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. Journal of Neuroscience 19, 5782–5791.
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., di Iorio, G., Golbe, L. I. & Nussbaum, R. L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047.
Raina, A. K., Hochman, A., Zhu, X., Rottkamp, C. A., Nunomura, A., Siedlak, S. L., Boux, H., Castellani, R. J., Perry, G. & Smith, M. A. (2001) Abortive apoptosis in Alzheimer's disease. Acta Neuropathologica (Berlin) 101, 305–310.
Roth, K. A. (2001) Caspases, apoptosis, and Alzheimer disease: Causation, correlation, and confusion. Journal of Neuropathology and Experimental Neurology 60, 829–838.
Saha, A. R., Ninkina, N. N., Hanger, D. P., Anderton, B. H., Davies, A. M. & Buchman V. L. (2000) Induction of neuronal death by alpha-synuclein. European Journal of Neuroscience 12, 3073–3077.
Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55–66.
Schmalbruch, H. (1988) The effect of peripheral nerve injury on immature motor and sensory neurons and on muscle fibres. Possible relation to the histogenesis of Werdnig-Hoffmann disease. Review of Neurology (Paris) 144, 721–729.
Schmitt, A. B., Breuer, S., Voell, M., Schwaiger, F. W., Spitzer, C., Pech, K., Brook, G. A., Noth, J., Kreutzberg, G. W. & Nacimiento, W. (1999) GAP-43 (B-50) and C-Jun are up-regulated in axotomized neurons of Clarke's Nucleus after spinal cord injury in the adult rat. Neurobiology of Disease 6, 122–130.
Schwaiger, F. W., Schmitt, G. H., Horvat, A., Hager, G., Streif, R., Spitzer, C., Gamal, S., Breuer, S., Brook, G. A., Nacimiento, W. & Kreutzberg, G. W. (2000) Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT). European Journal of Neuroscience 12, 1165–1176.
Serpell, L. C., Berriman, J., Jakes, R., Goedert, M. & Crowther, R. A. (2000) Fiber diffraction of synthetic alpha-synuclein filaments shows amyloidlike cross-beta conformation. Proceedings of the National Academy of Sciences of the USA 97, 4897–4902.
Sperandio, S., de Belle, I. & Bredesen, D. E. (2000) An alternative, nonapoptotic form of programmed cell death. Proceedings of the National Academy of Sciences of the USA 97, 14376–14381.
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proceedings of the National Academy of Sciences of the USA 95, 6469–6473.
Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. & Goedert, M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839–840.
Sumner, B. E. H. (1976) Quantitative ultrastructural observations on the inhibited recovery of the hypoglossal nucleus from the axotomy response when regeneration of the hypoglossal nerve is prevented. Experimental Brain Research 26, 141–150.
Tetzlaff, W., Graeber, M. B. & Kreutzberg, G. W. (1986) Reaction of motoneurons and their microenvironment to axotomy. Experimental Brain Research Suppl. 13, 3–8.
Tu, P. H., Galvin, J. E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. Q. & Lee, V. M. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Annals of Neurology 44, 415–422.
Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P. & Davies, S. W. (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the USA 97, 8093–8097.
Turnbull, S., Tabner, B. J., El-Agnaf, O. M., Moore, S., Davies, Y. & Allsop, D. (2001) Alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. Free Radical Biology and Medicine 30, 1163–1170.
Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y. & Saitoh, T. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proceedings of the National Academy of Sciences of the USA 90, 11282–11286.
van der Putten, H., Wiederhold, K. H., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. P., Ruegg, M. A., Lin, S., Caroni, P., Sommer, B., Tolnay, M. & Bilbe, G. (2000) Neuropathology in mice expressing human alpha-synuclein. Journal of Neuroscience 20, 6021–6029.
Watson, W. E. (1974) Cellular responses to axotomy and related procedures. British Medical Bulletin 30, 112–115.
Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A. & Lansbury, P. T., Jr. (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709–13715.
Zhou, W., Hurlbert, M. S., Schaack, J., Prasad, K. N. & Freed, C. R. (2000) Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Research 866, 33–43.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moran, L.B., Kösel, S., Spitzer, C. et al. Expression of alpha-synuclein in non-apoptotic, slowly degenerating facial motoneurones. J Neurocytol 30, 515–521 (2001). https://doi.org/10.1023/A:1015697318437
Issue Date:
DOI: https://doi.org/10.1023/A:1015697318437